导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -32.55% | 4921/4982 |
| 近一周 | -3.25% | 4008/5419 |
| 近一月 | -6.58% | 3970/5423 |
| 近一季 | -15.26% | 3959/5358 |
| 近半年 | -28.44% | 5009/5131 |
| 近一年 | -27.38% | 4525/4733 |
| 近两年 | 22.05% | 3516/4208 |
| 近三年 | 18.11% | 2310/3661 |
| 成立以来 | 69.61% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-14.67% 4919/5130 |
-17.94% 5004/5464 |
- - |
- - |
| 2025 | 55.08% 666/5130 |
15.24% 257/4624 |
9.72% 457/4802 |
18.38% 3091/4970 |
3.60% 865/5130 |
| 2024 | 27.01% 94/4618 |
4.58% 544/4340 |
11.74% 21/4442 |
13.34% 1253/4550 |
-4.10% 2836/4618 |
| 2023 | -16.01% 2049/4216 |
1.23% 1997/3759 |
-8.44% 3066/3909 |
-2.69% 718/4055 |
-6.88% 2898/4209 |
| 2022 | -22.91% 1542/3578 |
-21.14% 2186/2804 |
15.69% 282/3205 |
-28.63% 3192/3430 |
18.40% 29/3570 |
| 2021 | -14.02% 1499/2717 |
-0.13% 402/1745 |
8.63% 1086/2232 |
-13.94% 2038/2560 |
-7.90% 2268/2708 |
| 2020 | 38.68% 751/1596 |
-11.91% 976/1036 |
14.64% 885/1256 |
6.75% 923/1472 |
28.64% 59/1690 |
| 2019 | - - |
- - |
- - |
- - |
13.94% 129/1014 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 0.9797 | 54.69% |
| 招商创新增长混合A | 1.0526 | 54.25% |
| 招商创新增长混合C | 1.0013 | 53.96% |
| 华泰柏瑞医疗健康A | 2.5834 | 49.29% |
| 招商品质成长混合A | 1.0196 | 49.15% |
| 大摩优悦安和混合A | 0.8851 | 47.23% |
| 大摩优悦安和混合C | 0.8688 | 47.08% |
| 华泰柏瑞医疗健康C | 2.5230 | 44.21% |
| 大摩健康产业混合A | 1.9140 | 32.70% |
| 中信建投医药健康A | 0.7640 | 31.75% |
| 汇丰晋信港股通双核策略混合 VS. 长安宏观策略混合A(740001) |